Roche Holding AG
OTCQX International Premier:RHHBY

  • LAST PRICE
    40.7600
  • TODAY'S CHANGE (%)
    1.2000 (3.0334%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    40.1500 / 39.5600
  • Day Range
    40.1200
    40.8000
  • 52 Week Range
    29.2000
    40.8000
  • Volume
    2,775,124

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

  • Yesterday

      Show headlines and story abstract

    • 12:16PM ET on Thursday Jul 25, 2024 by Dow Jones
      Companies Mentioned: RHHBY

      This article was automatically generated using Dow Jones technology.

      Shares of Roche Holding AG advanced 1.5% to CHF277.50 Thursday on what proved to be an overall poor trading session for the stock market, with the Swiss SMI Index falling 0.8% to 12,105.54.

    • 3:35AM ET on Thursday Jul 25, 2024 by Dow Jones
      Companies Mentioned: RHHBY

      0734 GMT - Roche Holding surprised with an increase to its full-year earnings guidance after core profit for the first half beat expectations helped by stronger-than-anticipated margins, Jefferies analysts say in a research note. The Swiss pharmaceutical company now expects core earnings per share to grow in the high single percentage digit range excluding currency movements and the impact from tax disputes in 2023, having previously guided for mid-single-digit growth. While current consensus expectations already sit at the mid-point of Roche's new guidance range, there is room for potential upgrades to estimates of between 2% and 5%, Jefferies says. Core operating profit margin at the company's pharma business was well above consensus at 50.4% for the first half, while diagnostics profitability was better than expected as well, Jefferies says. Shares rise 2.6%. (adria.calatayud@wsj.com)

    • 2:59AM ET on Thursday Jul 25, 2024 by Dow Jones
      Companies Mentioned: RHHBY

      By Helena Smolak

      Roche Holding raised its profit outlook for the year after first-half sales and earnings rose, beating analysts' expectations, on growth in its pharmaceuticals and diagnostics businesses.

    • 1:01AM ET on Thursday Jul 25, 2024 by Dow Jones
      Companies Mentioned: RHHBY

      By Helena Smolak

      Roche raised its earnings outlook for the year after first-half sales and earnings rose, beating analysts' expectations.

      The Swiss pharmaceutical giant said Thursday that it now expects its core earnings per share to grow by a high single-digit percentage at constant currencies when excluding the impact from tax disputes in 2023, having previously guided for mid-single-digit growth. It continues to expect sales growth in the mid-single-digit range at constant exchange rates in 2024.

Peers Headlines